SC Filed 2020-04-29 Event — SEC 0001193125-20-126362 →

Frazier Life Sciences VIII, L.P. → Sierra Oncology, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Sierra Oncology, Inc.

Filed	Form	Filer	Stake	Shares
2022-07-11	SC	Abingworth LLP	—	—	view →
2022-03-21	SC	Abingworth LLP	—	—	view →
2022-03-15	SC	ORBIMED ADVISORS LLC	—	—	view →
2022-02-10	SC	Abingworth LLP	—	—	view →
2022-02-04	SC	Longitude Capital Partners III, LLC	—	—	view →
2022-02-02	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-11-08	SC	Longitude Capital Partners III, LLC	—	—	view →
2021-11-05	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-11-05	SC	Abingworth LLP	—	—	view →

Other Filings by Frazier Life Sciences VIII, L.P.

Filed	Form	Issuer	Stake	Shares
2023-10-26	SC	Arcutis Biotherapeutics, Inc. ARQT	—	—	view →
2022-02-15	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →
2021-09-21	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →
2021-05-12	SC	Arcutis Biotherapeutics, Inc. ARQT	—	—	view →
2021-05-04	SC	Aptinyx Inc.	—	—	view →
2021-02-09	SC	Arcutis Biotherapeutics, Inc. ARQT	—	—	view →
2021-02-04	SC	Aptinyx Inc.	—	—	view →
2020-03-23	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2020-01-16	SC	Aptinyx Inc.	—	—	view →
2020-01-13	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2019-01-23	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →